Craig-Hallum Downgrades PLAYSTUDIOS to Hold
Craig-Hallum analyst Ryan Sigdahl downgrades PLAYSTUDIOS (NASDAQ:MYPS) from Buy to Hold.
This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
PLAYSTUDIOS’ playAWARDS Partners With Experiential Entertainment Brand Lighthouse Immersive
playAWARDS, the loyalty marketing division of mobile gaming leader PLAYSTUDIOS, has added experiential entertainment brand Lighthouse Immersive to its growing portfolio of reward partners. Lighthouse
Stephen J. Cloobeck Releases Open Shareholder Letter Demanding Playstudios Replace Management
Stephen J. Cloobeck, a successful entrepreneur and substantial shareholder in Playstudios Inc. ("Playstudios" or "the Company"), today released a letter to the Company's Board of Directors
Executives Buy Over $1.5M Of 4 Penny Stocks
All major European indices regained ground on Friday. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
4 Penny Stocks Insiders Are Buying
US crude oil futures traded higher by around 4% on Friday. Investors, meanwhile, focused on some notable insider trades
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Oppenheimer Maintains Outperform on PLAYSTUDIOS, Lowers Price Target to $8
Oppenheimer maintains PLAYSTUDIOS (NASDAQ:MYPS) with a Outperform and lowers the price target from $9 to $8.